×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Capital Increase in Genmab as a Result of Employee Warrant Exercise
GlobeNewswire
Company Announcement COPENHAGEN, Denmark; May 7, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6959 shares as a...
2 days ago
Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run?
Yahoo News Singapore
Genmab AS Sponsored ADR (GMAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's...
1 day ago
Genmab A/S (OTCMKTS:GNMSF) Stock Crosses Below 200-Day Moving Average of $296.91
Defense World
Read Genmab A/S (OTCMKTS:GNMSF) Stock Crosses Below 200-Day Moving Average of $296.91 at Defense World.
16 hours ago
Pfizer, Genmab get full FDA approval for cervical-cancer drug
Morningstar
By Ben Glickman. Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms...
1 week ago
Genmab A/S (NASDAQ:GMAB) Receives Average Recommendation of "Hold" from Brokerages
MarketBeat
Shares of Genmab A/S (NASDAQ:GMAB - Get Free Report) have been given an average rating of "Hold" by the thirteen analysts that are covering...
7 hours ago
Genmab A/S Capital Boosted by Warrant Exercises - TipRanks.com
Tipranks
Genmab (Otc) (GMAB) has released an update. Genmab A/S announces a share capital increase by 6959 shares following the exercise of employee...
2 days ago
Pfizer, Genmab get full FDA approval for cervical-cancer drug
MarketWatch
Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical...
1 week ago
Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio
Investopedia
Danish drugmaker Genmab said Wednesday it plans to acquire U.S. biotech firm ProfoundBio for $1.8 billion in cash to expand its cancer...
1 month ago
Pfizer, Genmab’s ADC Tivdak Scores Full FDA Approval in Recurrent or Metastatic Cervical Cancer
BioSpace
Based on strong overall and progression-free survival data in its Phase III confirmatory study, Pfizer and Genmab's antibody-drug conjugate...
1 week ago
Genmab inks $1.8B ProfoundBio buyout for would-be Elahere rival, teeing up scrap for ADC market
Fierce Biotech
ProfoundBio is developing ADCs that target CD70 and PTK7 plus a bispecific ADC that hits EGFR and cMET. Genmab contends the combination of its...
1 month ago